| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Department of Endocrinology (J.J.D.), Hospital Ramón y Cajal, 28034 Madrid, Spain; Department of Endocrinology (P.I.), Hospital General, 40002 Segovia, Spain; and Endocrine Section (K.D.B.), Washington Hospital Center, Washington, D.C. 20010
Address all correspondence and requests for reprints to: Juan J. Díez, Department of Endocrinology, Hospital Ramón y Cajal, Carretera Colmenar km 9, 28034 Madrid, Spain. E-mail: mibarsd{at}infomed.es.
Context: Patients with subclinical hypothyroidism may revert to normal TSH values.
Objective: The objective of this study was to examine the time course of the normalization of TSH levels in subclinical hypothyroidism.
Design: This was a prospective, observational study with no intervention, with a duration of follow-up of 12–72 months.
Setting: Outpatients visited an endocrinology clinic of a general hospital.
Patients: Forty patients (32 women, mean age 62.8 ± 8.2 yr) with spontaneous subclinical hypothyroidism (TSH > 5 mU/liter and normal free T4) participated in the study. Each patient normalized their TSH values without T4 therapy throughout the follow-up.
Measurements: TSH and free T4 levels were evaluated every 6 months.
Results: Normalization occurred at a median time of 18 months (range, 6–60 months). Fifteen patients normalized their TSH levels during the first year of follow-up and 27 during the first 2 yr. Ten patients normalized their TSH values at the fourth or fifth year. Only four patients reverted to TSH values less than 2 mU/liter. Final TSH levels achieved by the patients were significantly correlated with the time elapsed until normalizing these levels (r = 0.367; P = 0.020).
Conclusions: There is no clear pattern of TSH normalization, although most patients normalize their TSH values early in the follow-up. The final TSH reached seems to be related to the time of normalization.
This article has been cited by other articles:
 |
|
 |
|
  L. Lazar, R. B.-D. Frumkin, E. Battat, Y. Lebenthal, M. Phillip, and J. Meyerovitch Natural History of Thyroid Function Tests over 5 Years in a Large Pediatric Cohort J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1678 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wasniewska, M. Salerno, A. Cassio, A. Corrias, T. Aversa, G. Zirilli, D. Capalbo, M. Bal, A. Mussa, and F. De Luca Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence Eur. J. Endocrinol., March 1, 2009; 160(3): 417 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Meyerovitch, P. Rotman-Pikielny, M. Sherf, E. Battat, Y. Levy, and M. I. Surks Serum Thyrotropin Measurements in the Community: Five-Year Follow-up in a Large Network of Primary Care Physicians Arch Intern Med, July 23, 2007; 167(14): 1533 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Brabant, P Beck-Peccoz, B Jarzab, P Laurberg, J Orgiazzi, I Szabolcs, A P Weetman, and W M Wiersinga Is there a need to redefine the upper normal limit of TSH? Eur. J. Endocrinol., May 1, 2006; 154(5): 633 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wartofsky and R. A Dickey The Evidence for a Narrower Thyrotropin Reference Range Is Compelling J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5483 - 5488. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
